Equillium, Inc. Income Statement
EQ|4 years of annual SEC 10-K data (FY2022-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
Equillium, Inc. reported $41M in revenue and $8M in net loss for FY2025. Revenue has grown at a 37.6% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $41.1M | $36.1M | $15.8M | $15.8M |
| SG&A Expense | $11.9M | $13.6M | $17.2M | $11.4M |
| R&D Expense | $37.4M | $37.0M | $37.5M | $26.4M |
| Operating Income | -$8.3M | -$14.5M | -$62.1M | -$37.8M |
| Interest Expense | - | $491.0K | $1.1M | $1.1M |
| Income Tax | $361.0K | $580.0K | $0 | $0 |
| Net Income | -$8.1M | -$13.3M | -$62.4M | -$39.1M |
| EPS (Basic) | -$0.23 | -$0.38 | -$1.85 | -$1.36 |
| EPS (Diluted) | -$0.23 | -$0.38 | -$1.85 | -$1.36 |
| Shares Outstanding | 35.6M | 35.3M | 34.4M | 29.5M |
| Operating Margin | -20.1% | -40.2% | -393.9% | -239.8% |
| Profit Margin | -19.6% | -37.0% | -396.1% | -247.8% |